Transition Therapeutics Inc (NASDAQ:TTHI)

7.96
Delayed Data
As of 4:00pm ET
 +0.06 / +0.76%
Today’s Change
4.36
Today|||52-Week Range
8.05
+16.43%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Transition Therapeutics Inc have a median target of 10.00, with a high estimate of 10.39 and a low estimate of 8.63. The median estimate represents a +25.63% increase from the last price of 7.96.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Transition Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$0.00
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 57.36%
 
 
 
 
 
 
Growthannually -62.21%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account